Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Stopped early
Conditions studied: Neuroendocrine Tumors, Brain (Nervous System) Cancers, Colon/Rectal Cancer, Colon Cancer, Hepatobiliary Cancers, Hepatocellular Carcinoma (Hepatoma), Liver
In brief
A research study of liver perfusion (how blood flows to the liver over time). We hope to learn whether perfusion characteristics of liver masses may be predictive of response to treatment and whether liver perfusion characteristics can be used to follow response to treatment.
Key facts
- Study ID
- NCT01163526
- Run by
- Stanford University
- People needed
- 13
- Starts
- 2010-09-01
- Expected to finish
- 2016-07-01
- Last updated by the study team
- 2017-01-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.